TABLE 2.
Specificities of MAbs used in this study
| MAb | Made to: | Specificity | Isotype | Source (reference) |
|---|---|---|---|---|
| 5D7 | H. somnus | NDa | IgG3 | This work |
| 5F5.9 | Haemophilus agyptius | PCho | IgG3 | A. Lesse |
| 59.6C5 | S. pneumoniae | PCho | IgG3 | D. Briles (4) |
| TEPC-15 | Natural murine myeloma cell line | PCho | IgA | M. Potter |
| 3F11 | N. gonorrhoeae | Galβ(1-4)GlcNAc | IgM | M. Apicella (3) |
| 6B4 | N. gonorrhoeae | Galβ(1-4)GlcNAcβ(1-3)Galβ(1-4)Glc | IgM | M. Apicella (3) |
| MAHD7b | H. ducreyi | Glcβ(1-4)Hepα(1-)Kdo(P)- | ND | A. Ahmed (1, 2) |
| α↑(1-3) | ||||
| Hepα(1-2)Hepα |
a
ND, not determined.
b
Suggested specificity given for this MAb.